Edition:
United States

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

6.06USD
9 Dec 2016
Change (% chg)

$-0.04 (-0.66%)
Prev Close
$6.10
Open
$6.12
Day's High
$6.13
Day's Low
$6.06
Volume
3,752
Avg. Vol
10,579
52-wk High
$7.16
52-wk Low
$4.39

SVA.OQ

Chart for SVA.OQ

About

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1)... (more)
No analyst recommendations are available for SVA.OQ.

Overall

Beta: 0.28
Market Cap(Mil.): $345.99
Shares Outstanding(Mil.): 56.91
Dividend: --
Yield (%): --

Financials

  SVA.OQ Industry Sector
P/E (TTM): -- 29.74 30.35
EPS (TTM): -0.19 -- --
ROI: -10.93 15.90 15.27
ROE: -9.16 17.00 16.60

BRIEF-Sinovac reports 71.4 pct rise in Q3 revenue

* Sinovac reports unaudited third quarter 2016 financial results

Nov 28 2016

BRIEF-Sinovac posts Q2 loss of $0.17/share

* Sinovac reports unaudited second quarter 2016 financial results

Aug 23 2016

Competitors

Earnings vs. Estimates